Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07674966 · ClinicalTrials.gov registry record · Phase 1
An Investigation of Topical Ophthalmic Low-Dose Atropine on Pupil Size and Accommodation
A Phase 1 study, sponsored by University of California, Berkeley.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT07674966 is a Phase 1 study that has completed, run by University of California, Berkeley. The registered enrollment target is 24 participants.
The verdict
NCT07674966, a Phase 1 study, has completed, sponsored by University of California, Berkeley.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
The goal of this clinical study is to learn about the short-term physiological effects of low-dose atropine in healthy volunteers. The study seeks to examine three questions related to low-dose topically applied ophthalmic atropine: 1. Does applying two drops of 0.01% atropine sulfate solution cause the same clinical effects as one drop of 0.02% atropine? 2. How quickly do the pupil responses and accommodative amplitudes recover following a dose of 0.01% atropine, 0.02% atropine, and 0.05% atropine? 3. Does applying a single drop of 0.02% atropine sulfate solution cause the same clinical effects in participants with light vs. dark iris colors? Participants will have their pupil size and accommodative status measured at appropriate intervals to answer the questions above.
Interventions
- DRUG Atropine 0.01% Ophthalmic Solution
- DRUG Atropine 0.02% Ophthalmic Solution
- DRUG Atropine 0.05% Ophthalmic Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2022-03-16 |
| Est. Completion | 2022-10-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07674966
The ClinicalTrials.gov registry entry for NCT07674966 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Berkeley, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Atropine 0.01% Ophthalmic Solution is the first listed.
NCT07674966 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07674966 about?
NCT07674966 is a clinical study titled "An Investigation of Topical Ophthalmic Low-Dose Atropine on Pupil Size and Accommodation". The goal of this clinical study is to learn about the short-term physiological effects of low-dose atropine in healthy volunteers. The study seeks to examine three questions related to low-dose topically applied ophthalmic atropine: 1. Does applying two drops of 0.01% atropine sulfate solution caus...
What is the current status of trial NCT07674966?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2022-03-16. Estimated completion is 2022-10-09.
What interventions are being tested in trial NCT07674966?
The interventions under investigation include: Atropine 0.01% Ophthalmic Solution (DRUG), Atropine 0.02% Ophthalmic Solution (DRUG), Atropine 0.05% Ophthalmic Solution (DRUG).
Who is sponsoring clinical trial NCT07674966?
This trial is sponsored by University of California, Berkeley, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.